Spatial control of Cdc42 signalling by a GM130-RasGRF complex regulates polarity and tumorigenesis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 25208761.
- Also identified by DOI 10.1038/ncomms5839 and PMC identifier 4449154.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The small GTPase Cdc42 is a key regulator of polarity, but little is known in mammals about its spatial regulation and the relevance of spatial Cdc42 pools for polarity. Here we report the identification of a GM130-RasGRF complex as a regulator of Cdc42 at the Golgi. Silencing GM130 results in RasGRF-dependent inhibition of the Golgi pool of Cdc42, but does not affect Cdc42 at the cell surface. Furthermore, active Cdc42 at the Golgi is important to sustain asymmetric front-rear Cdc42-GTP distribution in directionally migrating cells. Concurrent to Cdc42 inhibition, silencing GM130 also results in RasGRF-dependent Ras-ERK pathway activation. Moreover, depletion of GM130 is sufficient to induce E-cadherin downregulation, indicative of a loss in cell polarity and epithelial identity. Accordingly, GM130 expression is frequently lost in colorectal and breast cancer patients. These findings establish a previously unrecognized role for a GM130-RasGRF-Cdc42 connection in regulating polarity and tumorigenesis.
Medical subject headings
- Autoantigens
- Carcinogenesis
- Cell Polarity
- Gene Expression Regulation, Neoplastic
- Membrane Proteins
- cdc42 GTP-Binding Protein
- ras Guanine Nucleotide Exchange Factors
- ras-GRF1